Advertisement

Gut Microbiota Imbalance Can Be Associated with Non-malabsorptive Small Bowel Shortening Regardless of Blind Loop

  • Eduardo Lemos de Souza Bastos
  • Ana Maria Alvim Liberatore
  • Roberto Carlos Tedesco
  • Ivan Hong Jun Koh
Original Contributions

Abstract

Introduction

Some traditional bariatric surgery procedures may lead to functional gut shortening, which may unsettle the fine-tuned gastrointestinal physiology and affect gut microbiota balance.

Purpose

Evaluate the gut microbiota behavior in rat models facing gut shortening due to intestinal bypass.

Materials and Methods

Wistar rats (n = 17) were randomly distributed in three groups: (1) sham group (n = 5); (2) blind loop group (n = 6); and (3) resection group (n = 6). Intestinal samples and feces were analyzed to measure bacterial concentrations (small intestinal bacterial overgrowth—SIBO) 12 weeks after the experimental procedures. Bacterial translocation (BT) was investigated in the mesenteric lymph node (MLN), liver, spleen, and lung of the animals. In addition, inflammatory aspects were investigated in their liver and small bowel through histological analysis.

Results

Regardless of blind loop, gut shortening groups recorded similar high level of bacterial concentrations in intestine compartments, greater than that of the sham group (p ≤ 0.05). BT was only observed in the MLN of gut shortening models, with higher percentage in the blind loop group (p ≤ 0.05). The gut and liver histopathological analysis showed similar low-grade chronic inflammation in both gut shortening groups, likely associated with SIBO/BT events.

Conclusion

Sustained SIBO/BT was associated with proximal gut shortening in half regardless of blind loop, whereas the GI tract’s ability to restore gut microbiota balance after a surgical challenge on the small bowel appears to be linked to the functional remaining gut.

Keywords

Microbiota Intestinal bypass Blind loop syndrome Rats 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All applicable institutional and national guidelines for the care and use of animals were followed. The present study was previously approved by Local Ethics Committee (UNIFESP – 0215/11).

Informed Consent

Does not apply.

References

  1. 1.
    The GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.CrossRefGoogle Scholar
  2. 2.
    Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018. [Epub ahead of print].Google Scholar
  3. 3.
    Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376(7):641–51.CrossRefGoogle Scholar
  4. 4.
    English WJ, DeMaria EJ, Brethauer SA, et al. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis. 2018;14(3):259–63.CrossRefGoogle Scholar
  5. 5.
    Ramos AC, Silva AC, Ramos MG, et al. Simplified gastric bypass: 13 years of experience and 12,000 patients operated. Arq Bras Cir Dig. 2014;27(Suppl 1):2–8.CrossRefGoogle Scholar
  6. 6.
    Griffen Jr WO, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977;186(4):500–9.CrossRefGoogle Scholar
  7. 7.
    Nora M, Morais T, Almeida R, et al. Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes? Medicine (Baltimore). 2017;96(48):1–7.CrossRefGoogle Scholar
  8. 8.
    Murad AJ, Cohen RV, de Godoy EP, et al. A prospective single-arm trial of modified long biliopancreatic and short alimentary limbs roux-En-Y gastric bypass in type 2 diabetes patients with mild obesity. Obes Surg. 2018;28(3):599–605.CrossRefGoogle Scholar
  9. 9.
    Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178ra141.CrossRefGoogle Scholar
  10. 10.
    Kong LC, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am Soc Nutr. 2013;98:16–24.Google Scholar
  11. 11.
    Osto M, Abegg K, Bueter M, et al. Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine. Physiol Behav. 2013;119:92–6.CrossRefGoogle Scholar
  12. 12.
    Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22:228–38.CrossRefGoogle Scholar
  13. 13.
    Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8(1):67.CrossRefGoogle Scholar
  14. 14.
    Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science. 2010;330(6012):1768–73.CrossRefGoogle Scholar
  15. 15.
    Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–70.CrossRefGoogle Scholar
  16. 16.
    Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258–70.CrossRefGoogle Scholar
  17. 17.
    Bures J. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978–90.CrossRefGoogle Scholar
  18. 18.
    Koh IHJ, Montero E, Guatelli R, et al. Comparative study of bacterial translocation in small bowel and colon in rats. Rev Col Bras Cir. 1995;22:30–2.Google Scholar
  19. 19.
    Koh IHJ, Montero EF, Keller R, et al. Bacterial concentration versus bacterial translocation. An experimental study in rats. Rev Col Bras Cir. 1995;22:38–9.Google Scholar
  20. 20.
    Xue H, Song D, Shi B, et al. Tracking of green fluorescent protein labeled Escherichia coli confirms bacterial translocation in blind loop rat. J Surg Res. 2007;143(2):206–10.CrossRefGoogle Scholar
  21. 21.
    Viddal K. Intestinal bypass. A randomized, prospective clinical study of end-to-side and end-to-end jejunoileal bypass. Scand J Gastroenterol. 1983;18(5):627–34.CrossRefGoogle Scholar
  22. 22.
    Rosina M, Micheletto G, Vita PM, et al. Intestinal jejunoileal microflora bypass settlement for morbid in patients obesity with. Obes Surg. 1993;3:239–45.CrossRefGoogle Scholar
  23. 23.
    Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–99.CrossRefGoogle Scholar
  24. 24.
    Sabaté JM, Jouët P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18(4):371–7.CrossRefGoogle Scholar
  25. 25.
    De Minicis S, Rychlicki C, Agostinelli L, et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology. 2014;59(5):1738–49.CrossRefGoogle Scholar
  26. 26.
    Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50(11):2374–83.CrossRefGoogle Scholar
  27. 27.
    Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.CrossRefGoogle Scholar
  28. 28.
    Ley R, Turnbaugh P, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3.CrossRefGoogle Scholar
  29. 29.
    Tilg H. Obesity, metabolic syndrome, and microbiota multiple interactions. J Clin Gastroenterol. 2010;44:16–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Eduardo Lemos de Souza Bastos
    • 1
  • Ana Maria Alvim Liberatore
    • 2
  • Roberto Carlos Tedesco
    • 3
  • Ivan Hong Jun Koh
    • 4
  1. 1.Department of Gastrointestinal SurgeryMarilia Medicine SchoolMariliaBrazil
  2. 2.Experimental Research LaboratoryFederal University of Sao PauloSao PauloBrazil
  3. 3.Department of Morphology and GeneticsFederal University of Sao PauloSao PauloBrazil
  4. 4.Department of Surgery and Experimental Research LaboratoryFederal University of Sao PauloSao PauloBrazil

Personalised recommendations